Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Imidazolidinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1067058C details a continuous addition method for producing >99.9% purity DMI, eliminating imine by-products for electronic and polymer applications.
Patent CN1176249A reveals a continuous process for >99.9% purity imidazolidinones. Ideal for reliable specialty solvent supplier partnerships and cost reduction in fine chemical manufacturing.
Patent CN101395140B reveals a high-yield process for 2-imidazolidinones using solid acid catalysts and hydrogenation, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Analysis of patent CN1243001C reveals a scalable aqueous synthesis route for Sertindole intermediates, offering significant cost reduction and environmental compliance advantages for pharmaceutical supply chains.